Perioperative Considerations of Novel Antidiabetic Agents in Heart Failure Patients Undergoing Cardiac Surgery

Perioperative Considerations of Novel Antidiabetic Agents in Heart Failure Patients Undergoing Cardiac Surgery

Diabetes mellitus (DM) is a major risk factor for cardiovascular disease, including heart failure (HF). A high proportion of DM patients eventually require cardiac surgery. While the traditional approach to DM therapy focuses on tight glucose control with insulin and oral hypoglycemic agents, novel...

Full description

Saved in:
Bibliographic Details
Main Authors: Ashley Wang, Savannah Bitzas, Dilsa Perez, Jonathon Schwartz, Saleem Zaidi, Jonathan Oster, Sergio D. Bergese
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Life
Subjects:
diabetes mellitus
heart failure
GLP-1 receptor agonist
DPP-4 inhibitors
SGLT2 inhibitors
cardiac surgery
Online Access:https://www.mdpi.com/2075-1729/15/3/427
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2075-1729/15/3/427

Similar Items